JAN 15, 2020 1:04 PM PST

Treating Malaria: Molecular Understanding of Drug Interactions

WRITTEN BY: Nouran Amin

Crystallization is a process central to drug development that despite centuries of facilitating a particular method, chemists are still learning how to grasp the complexity of drug interactions that involve the building and dissolution of crystals.

For the very first time, researchers have reported in the journal Nature what occurs at the molecular level when two compounds inhibit the growth of crystals. In the study, researchers examine these interactions between two antimalarial drugs

"You would expect using two drugs that attacked crystallization in two different ways would be synergistic, or at the very least additive," said Jeffrey Rimer, Abraham E. Dukler Professor of Chemical and Biomolecular Engineering at UH and a co-author of the paper. "Instead, we found that they can work against each other."

When drugs work against each other, this is known as antagonistic cooperation and can result in an infective treatment. In the case of the study, researchers were hopeful to treat Malaria by first understanding the molecular level of drug targets.

Malaria is a mosquito-borne disease that is often fatal killing more children than adults. It is caused by a parasite that devours the oxygen-carrying molecule found in our blood, hemoglobin. When it does so, it leaves behind a compound known as ‘hematin’ that the parasite sequesters into a crystal.

In the study, researchers examined the growth of hematin crystals using for common antimalarial drugs---- chloroquine, quinine, mefloquine and amodiaquine. They were able to characterize the mechanisms that these compounds utilize to inhibit crystal growth.

"This mechanism may provide guidance in the search for suitable inhibitor combinations to control crystallization of pathological, biomimetic, and synthetic materials," the researchers wrote. "In a broader context, our results highlight modifier interactions mediated by the dynamics and structures on the crystal interface as a prime element of the regulation of the shapes and patterns of crystalline structures in nature and industry."

Learn more about Malaria:

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JAN 20, 2020
Cell & Molecular Biology
JAN 20, 2020
Using Modified Red Blood Cells As a Drug Delivery System
For a drug to be effective, it has to get to the right place to exert its impact.
JAN 15, 2020
Drug Discovery & Development
JAN 15, 2020
A New Drug Target for Substance Abuse
Research carried out by the University of Minnesota Medical School indicates a new drug target for treating a drug addiction. Researchers note that the dru
FEB 12, 2020
Drug Discovery & Development
FEB 12, 2020
Diabetic Drug Increasces Risk of Heart Complications
A drug by the name of ‘rosiglitazone’ used to treat type 2 diabetes was found to be associated with increased risk of heart problems, especiall
MAR 08, 2020
Drug Discovery & Development
MAR 08, 2020
DNA Origami Helps With Cancer Therapeutics
A study published in the Proceedings of the National Academy of Sciences, describes how researchers designed molecules known as "peptoid-coated DNA or
MAR 18, 2020
Drug Discovery & Development
MAR 18, 2020
Drug Treatments Used For Cattle Affect Wildlife
Common drug treatments used in cattle, such as de-worming and anti-ectoparasitic products, have held effect on wildlife which urged researchers to find imm
APR 10, 2020
Cardiology
APR 10, 2020
Drinking Black Tea Reduces Risk of Heart Disease
Black tea is among one of the most commonly consumed beverages around the world. Beyond just being a refreshing and energizing beverage however, research s
Loading Comments...